Yantai Dongcheng Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Yantai Dongcheng Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥239.54 Million ≈ $35.05 Million USD) by net assets (CN¥5.66 Billion ≈ $827.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
Cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yantai Dongcheng Pharmaceutical Co Ltd (002675) share price today for real-time trading data and today's change.
Yantai Dongcheng Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Yantai Dongcheng Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Yantai Dongcheng Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ManpowerGroup Inc
NYSE:MAN
|
-0.061x |
|
The South Indian Bank Limited
NSE:SOUTHBANK
|
-0.457x |
|
Makalot Industrial Co Ltd
TW:1477
|
0.098x |
|
GigaCloud Technology Inc Class A Ordinary Shares
NASDAQ:GCT
|
0.132x |
|
Century Plyboards (India) Limited
NSE:CENTURYPLY
|
0.106x |
|
China Publishing & Media Hldg
SHG:601949
|
0.023x |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
|
0.027x |
|
Bayer Cropscience Limited
NSE:BAYERCROP
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. Review cash generation quality of Yantai Dongcheng Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.66 Billion ≈ $827.65 Million |
CN¥584.61 Million ≈ $85.55 Million |
0.103x | +93.35% |
| 2024-12-31 | CN¥5.37 Billion ≈ $786.01 Million |
CN¥287.15 Million ≈ $42.02 Million |
0.053x | +4.15% |
| 2023-12-31 | CN¥5.40 Billion ≈ $789.55 Million |
CN¥276.94 Million ≈ $40.53 Million |
0.051x | -72.79% |
| 2022-12-31 | CN¥5.28 Billion ≈ $772.97 Million |
CN¥996.54 Million ≈ $145.82 Million |
0.189x | +0.44% |
| 2021-12-31 | CN¥5.02 Billion ≈ $735.14 Million |
CN¥943.58 Million ≈ $138.08 Million |
0.188x | +62.89% |
| 2020-12-31 | CN¥4.97 Billion ≈ $726.63 Million |
CN¥572.58 Million ≈ $83.79 Million |
0.115x | -20.87% |
| 2019-12-31 | CN¥4.78 Billion ≈ $699.31 Million |
CN¥696.38 Million ≈ $101.90 Million |
0.146x | +36.26% |
| 2018-12-31 | CN¥4.61 Billion ≈ $674.68 Million |
CN¥493.06 Million ≈ $72.15 Million |
0.107x | +68.33% |
| 2017-12-31 | CN¥3.29 Billion ≈ $481.25 Million |
CN¥208.94 Million ≈ $30.57 Million |
0.064x | -0.18% |
| 2016-12-31 | CN¥3.08 Billion ≈ $451.28 Million |
CN¥196.28 Million ≈ $28.72 Million |
0.064x | +113.39% |
| 2015-12-31 | CN¥2.24 Billion ≈ $327.19 Million |
CN¥66.69 Million ≈ $9.76 Million |
0.030x | -32.08% |
| 2014-12-31 | CN¥1.18 Billion ≈ $173.30 Million |
CN¥52.00 Million ≈ $7.61 Million |
0.044x | +334.72% |
| 2013-12-31 | CN¥1.10 Billion ≈ $161.16 Million |
CN¥-20.60 Million ≈ $-3.01 Million |
-0.019x | -142.66% |
| 2012-12-31 | CN¥1.02 Billion ≈ $148.60 Million |
CN¥44.53 Million ≈ $6.52 Million |
0.044x | -90.38% |
| 2011-12-31 | CN¥304.42 Million ≈ $44.55 Million |
CN¥138.83 Million ≈ $20.31 Million |
0.456x | +52.81% |
| 2010-12-31 | CN¥191.06 Million ≈ $27.96 Million |
CN¥57.02 Million ≈ $8.34 Million |
0.298x | +257.54% |
| 2009-12-31 | CN¥140.43 Million ≈ $20.55 Million |
CN¥-26.60 Million ≈ $-3.89 Million |
-0.189x | -136.16% |
| 2008-12-31 | CN¥79.34 Million ≈ $11.61 Million |
CN¥41.57 Million ≈ $6.08 Million |
0.524x | -- |
About Yantai Dongcheng Pharmaceutical Co Ltd
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more